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ABSTRACT 
 
 
Health-Related Quality of Life and 
Family Impact in Children with 
Attention-Deficit/Hyperactivity Disorder 
and Co-Morbid Psychiatric Conditions. (May 2010) 
Christine Ashley Limbers, B.A., Santa Clara University; 
 M.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. James Varni  
                                                              Dr. Robert Heffer  
 
 
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent 
chronic disorders in childhood.  The measurement of health-related quality of life 
(HRQOL) can compliment ADHD behavior rating scales and provide a more 
comprehensive understanding of the impact of ADHD and its treatment on the child’s 
overall daily functioning and well-being.  The purpose of the current study was to assess 
HRQOL from the perspective of pediatric patient self-report and parent proxy-report and 
family impact from the perspective of parents in children with ADHD ages 5 to 18 years 
being seen at a Pediatric Psychiatric Clinic utilizing the PedsQL™ 4.0 Generic Core 
Scales and Family Impact Module.  For all PedsQL™ 4.0 Generic Core Scales, pediatric 
patients with ADHD and their parents reported statistically significant worse HRQOL 
than healthy children, with large effect sizes across all domains.  More impaired generic 
HRQOL was significantly correlated with more severe ADHD symptoms as measured 
by the NICHQ Vanderbilt Total ADHD Symptom Score for parent proxy-report but not 
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child self-report.  More impaired family functioning was significantly correlated with 
more severe ADHD symptoms.  Intraclass Correlations (ICC) between pediatric patient 
self-report and parent proxy-report across the PedsQL™ 4.0 Generic Core Scales were 
in the poor to fair agreement range.  These findings have implications for future research 
and clinical practice with pediatric patients with ADHD and co-morbid psychiatric 
conditions and their families.  Given the large effect sizes reported between the present 
sample and healthy children across all HRQOL domains, it is important that 
interventions designed for children with ADHD and co-morbid psychiatric conditions 
not only address psychosocial difficulties, but also the physical impairments that may 
result from medications and/or co-morbid psychiatric diagnoses such as anxiety or 
depression.  Given our finding that greater ADHD symptomatology was significantly 
associated with greater negative family impact, interventions for this population should 
focus on mitigating the negative impact of ADHD and co-morbid psychiatric conditions 
on families, particularly related to the areas of parental worry, family relationships, and 
daily family activities.   
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INTRODUCTION: HEALTH-RELATED QUALITY OF LIFE AND FAMILY IMPACT 
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic condition 
characterized by impulsivity, a developmentally inappropriate activity level, low 
frustration tolerance, poor organization of behavior, distractibility, and an inability to 
sustain attention and concentration (APA, 1994; Cormier, 2008).  ADHD is one of the 
most prevalent chronic disorders in childhood, affecting approximately 3% to 7% of 
school-aged children and accounting for nearly one third to one half of child mental 
health referrals (Daviss, 2008).  ADHD is diagnosed 3 times more often in boys than 
girls (Barkley, 1998).  ADHD symptoms are associated with impairments across a 
number of domains including academic, social, and emotional functioning (Spencer, 
Biederman, & Mick, 2007).  For example, children with ADHD are often 
underachieving in school, have significant problems in relationships with peers, teachers, 
and parents, and are at a higher-risk for developing anxiety, depression, and substance 
use disorders.  A growing body of evidence suggests that ADHD symptoms and 
associated impairments persist into adulthood for the majority of children with ADHD 
(Barkley, Fischer, Smallish, & Fletcher, 2006).  
ADHD Subtypes 
Three ADHD subtypes are defined in the Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition (DSM-IV): predominantly inattentive, predominantly 
hyperactive-impulsive, and a combined subtype (APA, 1994).  To meet DSM-IV  
_____________ 
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criteria for the predominantly inattentive or predominantly hyperactive-impulsive 
subtypes, at least 6 of 9 behaviors in one respective category must be endorsed (APA, 
1994).  Criteria for ADHD combined subtype is met when more than 6 behaviors are 
endorsed from each respective category (APA, 1994).  For all three subtypes, symptoms 
must be present prior to 7 years of age, last at least 6 months at a frequency greater than 
what would be expected in children of a comparable level of development, present in 
two or more settings, have a clear impact on psychosocial functioning, and which can’t 
be accounted for by other types of mental health or learning disorders (APA, 1994).  The 
ADHD combined subtype is most often diagnosed (50% to 75% of all individuals with 
ADHD), followed by the inattentive subtype (20%-30%), and the hyperactive-impulsive 
subtype (less than 15%) (Spencer et al., 2007).  Children diagnosed with the inattentive 
subtype are more likely to be girls and have less emotional and behavioral problems in 
comparison with the other subtypes; children diagnosed with the combined ADHD 
subtype tend to have the greatest overall impairments and have the highest frequency of 
co-morbid psychiatric disorders (Spencer et al., 2007).                          
ADHD and Co-Morbid Psychiatric Disorders 
 There is a high frequency of co-morbid (co-existing) psychiatric disorders in 
children with ADHD (Steinhausen et al., 2006).  In fact, some estimates suggest that in 
the general population, 2 in 3 children with ADHD meet DSM-IV criteria for one or 
more co-morbid psychiatric disorders (Kadesjo & Gillberg, 2001).  Co-morbid 
psychiatric disorders often associated with ADHD include oppositional defiant disorder 
(ODD), conduct disorder (CD), depression, bipolar disorder, anxiety, tic disorders, 
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obsessive compulsive disorder, autism spectrum disorders, learning disabilities, and 
mental retardation (Cormier, 2008).  ODD and CD are among the most prevalent co-
morbid psychiatric conditions in children with ADHD; 50% to 60% of children 
diagnosed with ADHD meet criteria for ODD while 25% of children diagnosed with 
ADHD meet criteria for CD (Kadesjo & Gillberg, 2001).  Mood and anxiety disorders 
also frequently co-exist with ADHD in that nearly one in four children with ADHD also 
meets criteria for a mood and/or anxiety disorder (Root & Resnick, 2003).  The co-
existence of ADHD with other psychiatric conditions in children has been associated 
with greater severity of ADHD symptoms and behavioral problems, and more 
substantial impairments in psychosocial functioning (Steinhausen et al., 2006).        
ADHD and Family Impact 
ADHD also has a profound impact on family functioning.  The social-ecological 
framework, based on the work of Dr. Urie Bronfenbrenner, provides a helpful model for 
understanding the interactions between a child with ADHD and the numerous systems 
relevant to the child, including the family (Bronfenbrenner, 1979).  Microsystems are the 
most proximal levels of influence on the child and involve the “pattern of activities, 
roles, and interpersonal relations” the child experiences (Bronfenbrenner, 1979).  
Included in the microsystem are settings and people the child frequently interacts with 
including school and family members such as parents and siblings (Roberts, 2003).  Also 
included in the microsystem of a child with a chronic health condition such as ADHD is 
the disease and its treatment (Roberts, 2003).  Mesosystems are “interrelated 
miscrosystems, or the overlap or two or more microsystems” (Roberts, 2003).  For 
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example, the mesosystem of a child with ADHD may involve interactions between 
teachers, parents, and health care providers who treat the child.  The exosystem involves 
aspects of the child’s environment that have significant indirect effects on the child 
(Roberts, 2003).  For example, this can include parental employment which is important 
since parents provide the majority of care for their children.   
A chronic health condition such as ADHD and its treatment can place a number 
of demands on a child’s family (Wallander & Varni, 1998).  In addition to the behavioral 
problems families of children with ADHD must cope with, parents are often faced with 
increased caretaking demands related to the delivery and management of the child’s 
medication and behavioral treatment programs (Riley, Lyman et al., 2006; Whalen et al., 
2006).  Strained parent-child and sibling relationships, less perceived family 
cohesiveness, parental depression, and higher rates of separation and divorce have been 
reported in families of children with ADHD (Brown & Pacinin, 1989; Kaplan, Crawford, 
Fisher, & Dewey, 1998).  Parents’ work status and work productivity have been shown 
to be negatively impacted by childhood ADHD (Coghill et al., 2008).   
Children’s academic problems have been shown to negatively impact family 
functioning (Kaplan et al., 1998).  To evaluate if the behavioral problems associated 
with ADHD impose a unique burden on families above and beyond general school 
difficulties, Kaplan et al. (1998) conducted a cross-sectional analysis of family 
functioning across a group of children with ADHD and a group of children with reading 
disabilities who had no reported behavior problems (Kaplan et al., 1998).  The authors 
found that families of children with ADHD reported significantly more impairments in 
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family functioning compared to families of children with reading disabilities.  These 
findings suggest that behavioral problems associated with ADHD pose a greater burden 
to families than general school problems (Kaplan et al., 1998).  However, as noted by the 
authors, these findings should be interpreted with caution given the familial nature of 
ADHD.  That is, many parents of children with ADHD may have characteristics of 
ADHD themselves which may contribute to family dysfunction (Kaplan et al., 1998).    
 There is a growing body of literature that suggests children with ADHD 
experience chronic sleep difficulties, which may in part be attributed to the side effects 
of medications used to treat ADHD (Lim, Ooi, Fung, Mahendran, & Kaur, 2008).  These 
sleep difficulties may further negatively impact family functioning and include problems 
initiating sleep (resisting bedtime, delayed onset sleep) and maintaining sleep (recurrent 
awakenings, restless sleep, nightmares, disordered breathing) (Sung, Hiscock, Sciberras, 
& Efron, 2008).  In a sample of 239 Australian children ages 5-18 years diagnosed with 
ADHD, Sung et al. (2008) found that 73.3% of children in their sample experienced 
sleep difficulties (28.5% mild sleep problems; 44.8% moderate or severe sleep 
problems) (Sung et al., 2008).  The authors reported a strong association between 
moderate or severe sleep problems and the mental health of the primary caregiver, 
family functioning, and the primary caregiver’s ability to fulfill daily responsibilities 
outside of the home (Sung et al., 2008).  Specifically, parents in the sample of children 
with moderate or severe sleeps problems were more likely to report missing work or 
being late for work in the previous 6 months (Sung et al., 2008).  A recent study by 
Mayes et al. (2009) found that children with ADHD combined subtype experienced 
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greater sleep difficulties than children with ADHD inattentive subtype; children with 
ADHD and co-morbid anxiety or depression experienced greater sleep problems than 
children with ADHD alone and children with ADHD and co-morbid ODD (Mayes et al., 
2009).                                           
Treatment of ADHD 
Consistent with the treatment of other chronic mental health conditions, the goal 
of treatment for ADHD is to reduce symptoms, improve functionality, and enhance well-
being for the child.  Three treatments are the mainstay for treating children with ADHD 
(Kratochvil et al., 2009).  These include behavioral interventions, central nervous 
stimulants, and a combination of the two.  Expert guidelines indicate that a combination 
of behavioral treatment and stimulant medication is the most effective treatment for 
children with ADHD, particularly given the considerable behavioral problems that 
negatively impact family and school functioning (Edwards, 2002).  Behavioral 
treatments for ADHD involve behavioral parent training and interventions in the 
classroom that attempt to alter the physical and social environment factors that lead to 
the maintenance of problematic child behavior; such training involves teaching parents 
and teachers specific techniques such as positive reinforcement, time-out, and “response 
cost” to reward positive behaviors and utilizing consequences for behaviors that are 
disruptive or noncompliant (Kratochvil et al., 2009). 
Two types of stimulant medications (methylphenidate and dextroamphetamine) 
are used most frequently to treat symptoms of ADHD.  Some data suggest that at least 
90% of children with ADHD will respond positively to one stimulant with no major 
7 
 
adverse side effects when the medication is administered and dosed properly (Cormier, 
2008).  However, the use of stimulant medications to treat children with ADHD can be 
controversial given that some children experience adverse side effects including 
decreased appetite, headache or stomachache, delayed sleep onset, irritability, social 
withdrawal, and in a small number of children, motor tics (Kratochvil et al., 2009).  
Adverse side effects caused by stimulant medications tend to be transient and are 
typically managed by altering dosage and administration time (Daviss, 2008).  There has 
been growing support for the effectiveness of non-stimulant drugs such as atomoxetine 
for treating children with ADHD (Newcorn et al., 2008).       
Health-Related Quality of Life 
The last decade has evidenced a dramatic increase in the development and 
utilization of pediatric patient patient-reported outcomes (PROs) in an effort to improve 
pediatric patient health and determine the value of healthcare services (FDA, 2006).  By 
definition, PROs are self-report instruments that directly measure the patient’s 
perceptions of the impact of disease and treatment as clinical trial endpoints (FDA, 
2006).  PROs include multi-item health-related quality of life (HRQOL) instruments, as 
well as single-item symptom measures (e.g., pain visual analogue scale [VAS]) 
(Acquadro et al., 2003; Sherman, Eisen, Burwinkle, & Varni, 2006; Willke, Burke, & 
Erickson, 2004).  It has been extensively documented in the PRO measurement of 
children with chronic health conditions and healthy children that information provided 
by proxy-respondents is not equivalent to that reported by the child (Eiser & Morse, 
2001a; Upton, Lawford, & Eiser, 2008).  This has been especially true for internal 
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domains such as emotional functioning, pain, and fatigue in which symptoms may only 
be known by the child (FDA, 2006).  Taken together, the findings on the proxy problem 
“indicate that parent reports cannot be substituted for child self-reports” (Theunissen et 
al., 1998) and evaluations of pediatric patients’ perspectives regarding treatment 
outcomes should be included in pediatric clinical trials given the documented differences 
between child and parent report.   
 HRQOL is a multidimensional construct (World Health Organization, 1948) and 
consistent with the World Health Organization’s definition of health, evaluates a 
patient’s subjective perception of the impact of disease and treatment on physical, 
psychological, and social functioning (World Health Organization, 1948).  A number of 
authors have argued that improving quality of life is the ultimate goal of healthcare 
(Kaplan, 2001).  Although the term “quality of life” (QOL) is sometimes used 
interchangeably with HRQOL, QOL is actually a broader construct that encompasses 
aspects of life which are not amenable to healthcare services (e.g., the evaluation of the 
impact of the built environment on general well-being).  Thus, HRQOL has emerged as 
the most appropriate term for QOL health dimensions which are within the scope of 
healthcare services (FDA, 2006).  
One of the most widely used models in pediatric psychology for understanding a 
child and family’s adjustment to a chronic health condition comes from Wallander and 
Varni (1998) (Wallander & Varni, 1998).  Within this theoretical framework, a chronic 
health condition is conceptualized as “an ongoing chronic strain for both the children 
and their parents” (Wallander & Varni, 1998).  Chronic strains are “persistent objective 
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conditions that require continual readjustment, repeatedly interfering with the adequate 
performance of ordinary role-related activities” (Wallander & Varni, 1998).  Risk factors 
in the model include: (1) disease/disability parameters (e.g., diagnosis, severity, 
visibility, brain damage, cognitive functioning), (2) functional independence in activities 
of daily living, and (3) psychosocial stressors (e.g., handicap-related problems, daily 
hassles, major life events).  Resistance factors in the model fall into 3 categories: (1) 
intrapersonal factors (e.g., temperament, competence, motivation, problem-solving 
ability), (2) social-ecological factors (e.g., family environment, family members’ 
adjustment, social support), and (3) stress processing factors (e.g., cognitive appraisal, 
coping strategies).  The main outcome in the model is consistent with the World Health 
Organization's definition of health, and which is currently defined conceptually as 
health-related quality of life (e.g., physical, mental, and social dimensions). 
ADHD and Health-Related Quality of Life 
Treatment response in children with ADHD often focuses on symptom reduction 
measured through behavioral rating scales completed by the child’s parents and teachers 
(Barkley, 1998).  These behavior rating scales such as the Conner’s Rating Scales are 
specific for behavioral characteristics of ADHD (e.g., inattention, hyperactivity, 
cognitive problems, oppositional behavior, anxiety, social problems) and therefore are 
limited in their ability to assess the child’s functioning broadly.  Furthermore, the 
majority of these behavior rating scales only offer parent and teacher reports for young 
children.  Consequently, they are unable to capture the young child’s perspective 
regarding his/her functioning.  The measurement of HRQOL can compliment ADHD 
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behavior rating scales and provide a more comprehensive understanding of the impact of 
ADHD and its treatment on the child’s overall daily functioning and well-being (Yang, 
Hsu, Chiou, & Chao, 2007).     
A number of recent studies have assessed HRQOL in children with ADHD 
(Bastiaens, 2008; A. F. Klassen, Miller, & Fine, 2004; Matza et al., 2004; Perwien et al., 
2004; Riley, Coghill et al., 2006; Sallee, Ambrosini, Lopez, Shi, & Michaels, 2004; 
Sawyer et al., 2002; Sung et al., 2008; Varni & Burwinkle, 2006; Yang et al., 2007; 
Svanborg et al., In press; Wigal et al., 2005).  These 12 studies are summarized in Table 
1.  While these studies are an important contribution to the empirical literature, 
demonstrating the substantial negative impact of ADHD on HRQOL, they provide a 
limited understanding of the HRQOL of children with ADHD since HRQOL was only 
evaluated via parent proxy-report for all but one of the studies (Varni & Burwinkle, 
2006).  The study by Varni & Burwinkle (2006) that assessed pediatric patient self-
reported HRQOL in children with ADHD had a number of methodological limitations.  
For example, this was a population-based study so children were identified by their 
parents as having ADHD, not by a physician (Varni & Burwinkle, 2006).  In addition, 
information on co-morbid psychiatric disorders was unavailable as was information on 
ADHD symptom severity (Varni & Burwinkle, 2006).  Given the far reaching 
psychosocial difficulties associated with ADHD, the adverse side effects that can result 
from stimulant medications, many of which involve internal symptoms such as loss of 
appetite, headaches, stomachaches, and irritability, and the well documented 
discrepancies between parent and child self-reports in the PRO literature, there is a need 
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for methodologically sound studies that assess HRQOL from the perspective of children 
with ADHD.   
Further, while 5 of the 12 studies summarized in Table 1 assessed the 
relationship between ADHD symptom severity and HRQOL, none of the studies used 
the Vanderbilt ADHD Diagnostic Rating Scales parent version (NICHQ, 2003) which is 
a well-validated measure of ADHD symptom severity consistent with the Diagnostic and 
Statistical Manual for Mental Disorders Fourth Edition (DSM-IV) (Froehlich, Lanphear, 
& Epstein, 2007; NICHQ, 2003; Wolraich, Lambert, & Doffing, 2003).  Two of the 
studies (Perwien et al., 2004; Yang et al., 2007) used the Clinical Global Impressions-
ADHD- Improvement, a single item measure of symptom severity based on the 
clinician’s evaluation of a child’s ADHD symptom severity in relation to the clinician’s 
total experience with ADHD symptoms.  A single item measure completed by a clinician 
who does not directly observe the child’s behavior in multiple settings may not be the 
most reliable and valid indicator of ADHD symptom severity.  In one study (A. F. 
Klassen et al., 2004), ADHD symptom severity was measured utilizing an instrument 
that has not been well-validated called the Child Symptom Inventory.  Two studies 
(Matza et al., 2004; Riley, Coghill et al., 2006) used the ADHD Rating Scale-IV Parent 
Version, which is an 18-item measure that corresponds to the DSM-IV diagnostic 
criteria for ADHD and has been widely used to assess ADHD symptom severity.  In a 
sample of 1,477 children ages 6-18 years diagnosed with ADHD, Riley et al. (2006) 
found that correlations between 5 of the 6 scales on the HRQOL measure CHIP-CE 
(Satisfaction, Comfort, Resilience, Academic Performance, and Peer Relations) and the 
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ADHD Rating Scale-IV Parent Version were in the small effect size range (Riley, 
Coghill et al., 2006).  In a sample of 297 children ages 8 to 17 years diagnosed with 
ADHD, Matza et al. (2004) found that the psychosocial functioning scales of the Child 
Health Questionnaire (CHQ) Parent Version and the ADHD Rating Scale-IV Parent 
Version were significantly negatively correlated (Matza et al., 2004).  In general, the 
CHQ physical scales were not significantly correlated with the measure of ADHD 
symptom severity.  While these two studies provide useful information on the 
associations between ADHD symptom severity and HRQOL, they were limited by the 
fact the analyses only included Pearson correlations and did not control for the presence 
of co-morbid psychiatric conditions.  Thus, it is unclear the impact co-morbid 
psychiatric conditions had on ADHD symptom severity and HRQOL in these two 
studies.  As such, there is a need for additional research that elucidates the relationship 
between ADHD symptom severity and HRQOL controlling for co-morbid psychiatric 
diagnoses.      
Finally, only one of the 12 published studies that assessed HRQOL in children 
with ADHD (Table 1) evaluated the relationship between HRQOL and family impact 
(Riley, Coghill et al., 2006).  Riley et al. (2006) correlated the Family Strain Index with 
the CHIP-CE.  The authors found that correlations between the Family Strain Index and 
5 of the 6 scales of the CHIP-CE (Satisfaction, Comfort, Resilience, Academic 
Performance, and Peer Relations) were in the medium effect size range.  The correlation 
between the Family Strain Index and the Risk Avoidance scale on the CHIP-CE was in 
the large effect size range.  While these findings point to the significant association 
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between impaired HRQOL and family functioning in children with ADHD, they are 
limited by the fact that they only include Pearson correlations.  Furthermore, the Family 
Strain Index is not a well-validated measure.  In fact, as noted by the authors, this study 
represented the first use of the Family Strain Index as it was developed specifically for 
the purposes of this investigation (Riley, Coghill et al., 2006).  Given the profound 
impact of ADHD on family functioning, there is a need to better understand the 
relationship between HRQOL and family impact in children with ADHD.   
The current study aims to address a gap in the literature by assessing HRQOL 
from the perspective of pediatric patient self-report and parent proxy-report and family 
impact from the perspective of parents in children with ADHD ages 5 to 18 years being 
seen at a Pediatric Psychiatric Clinic.  Specifically, this study: (a) compares child self-
reported and parent proxy-reported HRQOL for pediatric patients with a physician-
diagnosis of ADHD to a matched sample of healthy children, (b) investigates the 
interrelationships between child self-reported HRQOL, parent proxy-reported HRQOL, 
parent-reported family impact, ADHD symptom severity, and disease-specific 
indicators, and (c) evaluates agreement between child self-reported and parent proxy-
reported HRQOL.        
The following hypotheses were tested:   
1. Consistent with previous PedsQL™ findings utilizing child self-report and parent 
proxy-report in a population-based study (Varni & Burwinkle, 2006) of children 
with ADHD and findings utilizing other HRQOL proxy-report measures in this 
population (A. F. Klassen et al., 2004; Matza et al., 2004), children with ADHD 
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will demonstrate significantly lower HRQOL (effect sizes in the medium to large 
range) than a matched sample of healthy children for both child self-report and 
parent proxy-report, with the greatest differences demonstrated on psychosocial 
functioning.    
2. Consistent with previous findings with children with ADHD using parent proxy-
report (A. F. Klassen et al., 2004; Matza et al., 2004; Perwien et al., 2004; Yang 
et al., 2007), more severe ADHD symptoms will be associated with more 
impaired generic HRQOL.  
3. Greater impairments in the child’s HRQOL and more severe ADHD symptoms 
will be associated with greater negative family impact consistent with previous 
literature utilizing parent proxy-report (Riley, Coghill et al., 2006).        
4. Children and their parents will demonstrate moderate to good agreement 
regarding the child’s HRQOL as evidenced by Intraclass Correlations between 
0.41 to 0.80 consistent with the one previous population-based study that 
assessed HRQOL in children with ADHD from the perspective of both child self-
report and parent proxy-report (Varni & Burwinkle, 2006).  Parents will report 
lower mean HRQOL scores than children based on previous literature (Upton et 
al., 2008).    
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METHOD 
Participants  
The current study utilized a pre-existing database.  Participants were children 
with a physician diagnosis of ADHD ages 5–18 years (n = 179) and parents of children 
with a physician diagnosis of ADHD ages 5–18 years (n = 181) from a Pediatric 
Psychiatric Clinic.  This population of children with ADHD treated at a Pediatric 
Psychiatric Clinic were specifically selected given that it was anticipated that this a 
population of children would manifest a high prevalence of co-morbid psychiatric 
conditions (Epstein, Shawitz, Shaywitz, & Woolston, 1991; Wasserman et al., 1999).  
The average age of the 57 girls (31.1%) and 124 boys (67.8%; Missing, n = 2, 1.1%) was 
11.08 years (SD = 3.70).  With respect to race/ethnicity, the sample contained 147 
(80.3%) White non-Hispanic, 8 (4.4%) Hispanic, 20 (10.9%) Black non-Hispanic, 5 
(2.7%) Other, and 3 (1.6%) Missing.  Mean SES was 40.62 (SD = 11.71), indicating on 
average a middle to upper middle class sample based on the Hollingshead index 
(Hollingshead, 1975).  SES data was not available for 27 participants (14.9%).  Mean 
number of months since being diagnosed with ADHD for the sample was 43.68 months 
(SD = 32.19; Range = 1-153).  The median number of diagnoses children in the sample 
had was 2 (SD = 0.93; Range = 1-4).  88.0 % of the sample had at least one co-morbid 
diagnosis.  The co-morbid diagnoses were predominantly psychological disorders and 
included Mood Disorders (n = 82), Disruptive Behavior Disorders (n = 99), Anxiety 
Disorders (n = 52), Psychotic Disorders (n =7), Substance Use Disorders (n =1), 
Learning Disability/Mental Retardation (n =28), and Other (n = 13).    The median 
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number of daily medications children in the sample were taking was 1 (SD = 0.57; 
Range = 0-3); mean number of months children had been on medications was 42.09 (SD 
= 31.71; Range = 1-153).  98.4% of children in the sample were taking at least one daily 
medication to treat ADHD symptoms.  These medications included Adderall (n = 68), 
Concerta (n = 59), Strattera (n = 12), Ritalin (n = 9), Methylphenidate (n = 4), Dexedrine 
(n = 3), Dextrostat (n = 1), Focalin (n = 2), Methylin (n = 2), and Metadate (n = 1).  This 
sample is representative of the underlying population of children with ADHD in the 
United States which is more likely to be white males (Bimstein, Wilson, Guelmann, & 
Primosch, 2008).       
The healthy children sample was derived from the previously conducted 
PedsQL™ 4.0 initial field test (Varni, Seid, & Kurtin, 2001) and a statewide SCHIP 
evaluation in California (Varni, Burwinkle, Seid, & Skarr, 2003) and was randomly 
matched by age, gender, and race/ethnicity to the ADHD sample utilizing the SPSS 
Version 16.0 statistical software random sample case selection command. Children were 
assessed either in physicians’ offices during well-child visits, by telephone, or via a 
statewide mailing.  The average age of the 957 boys (65.9 %) and 496 girls (34.1 %) was 
9.21 years (SD = 4.46).  With respect to race/ethnicity, the sample contained 1170 (80.5 
%) White non-Hispanic, 112 (7.7 %) Hispanic, 131 (9.0 %) Black non-Hispanic, 26 
(1.8%) Other, and 14 (1.0%) Missing.  Mean socioeconomic status (SES) was 
unavailable for this sample, although the statewide SCHIP sample was representative of 
low-income families (< 250% of the federal poverty level).   
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Measures 
Generic Health-Related Quality of Life.  Generic health-related quality of life 
(HRQOL) was measured for both child self-report and parent proxy using the PedsQL™ 
4.0 Generic Core Scales (Pediatric Quality of Life Inventory™) (Varni et al., 2001).  The 
23-item PedsQL 4.0 Generic Core Scales were designed to measure the core 
dimensions of health (physical, mental, and social health) delineated by the World Health 
Organization (World Health Organization, 1948), as well as role (school) functioning. 
The PedsQL™ consists of brief, practical, generic core scales suitable for use with 
healthy school and community populations, as well as with pediatric populations with 
acute and chronic health conditions.  Pediatric self-report is measured in children and 
adolescents ages 5-18 years, and parent proxy-report of child HRQOL is measured for 
children and adolescents ages 2-18 years.  In this study, only children ages 5 to 18 years 
and their parents completed the PedsQL™ given the low prevalence of children with 
ADHD ages 2-4 years seen in the Psychiatry Clinic in which data was collected.  The 23-
item PedsQL™ 4.0 Generic Core Scales encompass: 1) Physical Functioning (8 items), 2) 
Emotional Functioning (5 items), 3) Social Functioning (5 items), and 4) School 
Functioning (5 items).  The instrument takes approximately 5 minutes to complete (Varni 
et al., 2001).  The PedsQL 4.0 Generic Core Scales has emerged as a widely used generic 
HRQOL measure in pediatric chronic health conditions that has resulted from an 
extensive iterative process involving numerous patient and parent focus groups and 
individual focus interviews, item generation, cognitive interviewing, pre-testing, and 
subsequent field testing (Varni & Limbers, 2009).  There are currently extensive 
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international data on thousands of healthy children and children with numerous pediatric 
chronic health conditions published or in press in over 350 peer-reviewed journals since 
2001 (A full listing of the updated peer-reviewed journal publications is available at 
www.pedsql.org).  The PedsQL™ 4.0 Generic Core Scales has been utilized in pediatric 
psychiatric disorders, demonstrating significant impairments in HRQOL and significant 
intercorrelations with the Child Behavior Checklist (Bastiaansen, Koot, Bongers, Varni, 
& Verhulst, 2004; Storch et al., 2007; Varni Seid, & Rode, 1999) and measures of 
emotional distress including the Children’s Depression Inventory (Cotton et al., 2009; 
Varni, Seid, & Rode, 1999; Anderson et al., in press), the State-Trait Anxiety Inventory 
for Children (STAIC) (Varni, Seid, & Rode, 1999), the Revised Children’s Manifest 
Anxiety Survey (RCMAS) (Anderson et al., in press), and the Social Phobia and Anxiety 
Inventory for Children and Short Mood and Feeling Questionnaire (Reinfjell, Hjemdal, 
Aune, Vikan, & Diseth, 2008). 
The PedsQL™ 4.0 Generic Core Scales has been shown to distinguish between 
healthy children and children with pediatric chronic health conditions (Field, Alpert, 
Vega-Lahr, Goldstein, & Perry, 1988; Palmer, Meeske, Katz, Burwinkle, & Varni, 2007; 
Uzark, Jones, Burwinkle, & Varni, 2003; Varni et al., 2006; Varni, Burwinkle, Katz, 
Meeske, & Dickinson, 2002; Varni, Burwinkle, Rapoff, Kamps, & Olson, 2004), 
demonstrated sensitivity to disease severity(Chan, Mangione-Smith, Burwinkle, Rosen, & 
Varni, 2005; Varni et al., 2006; Varni, Limbers, & Burwinkle, 2007), responsiveness 
through patient change over time (Connelly & Rapoff, 2006; Fullerton et al., 2007; 
Holterman et al., 2007; Razzouk et al., 2006; Varni, Seid et al., 2002), and shown 
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significant intercorrelations with disease-specific symptoms (Varni et al., 2006; Varni, 
Burwinkle, Jacobs et al., 2003).  The PedsQL™ 4.0 Generic Core Scales child self-report 
version has also demonstrated factorial invariance (stable factor structure) across age ( 
Limbers, Newman, & Varni, 2008a), gender (Varni, Limbers, & Newman, 2008), 
race/ethnicity (Limbers, Newman, & Varni, 2009), socioeconomic status (Limbers, 
Newman, & Varni, 2008), health status (Limbers, Newman, & Varni, 2008b), 
longitudinally (Varni, Limbers, Newman, & Seid, 2008), and across mode of 
administration (Varni, Limbers, & Newman, 2009).   
Family Impact. The 36-item PedsQL™ Family Impact Module Scales encompass 
6 scales measuring parent self-reported functioning: 1) Physical Functioning (6 items), 2) 
Emotional Functioning (5 items), 3) Social Functioning (4 items), 4) Cognitive 
Functioning (5 items), 5) Communication (3items), 6) Worry (5 items), and 2 scales 
measuring parent reported family functioning; 7) Daily Activities (3 items) and 8) Family 
Relationships (5 items).  Items and scales were developed through focus groups, 
cognitive interviews and pre-testing measurement development protocols (Varni, 
Sherman, Burwinkle, Dickinson, & Dixon, 2004), and our prior research and clinical 
experiences with children with chronic health conditions and their families.  The 
PedsQL™ Family Impact Module has demonstrated acceptable reliability and validity 
across a number of populations including children with sickle cell disease (Panepinto, 
Hoffmann, & Pajewski, 2009), developmental delays (Hsieh, Huang, Lin, Wu, & Lee, 
2009), cancer (Scarpelli et al., 2008), and medically fragile children with complex 
chronic health conditions (Varni, Sherman, Burwinkle, Dickinson, & Dixon, 2004). 
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The PedsQL™ Family Impact Module was developed as a parent-report 
instrument (Varni et al., 2004).  Likert response scale and scoring method for the Family 
Impact Module are identical to the PedsQL™ 4.0 Generic Core Scales, with higher scores 
indicating better functioning (less negative impact).  The PedsQL Family Impact Module 
Total Scale Score is the sum of all 36 items divided by the number of items answered.  
The Parent HRQOL Summary Score (20 items) is computed as the sum of the items 
divided by the number of items answered in the Physical, Emotional, Social, and 
Cognitive Functioning Scales.  The Family Functioning Summary Score (8 items) is 
computed as the sum of the items divided by the number of items answered in the Daily 
Activities and Family Relationships Scales. 
ADHD Symptom Severity.  Parents completed the parent version of the 
Vanderbilt ADHD Diagnostic Rating Scales (NICHQ, 2003).  The Vanderbilt ADHD 
Diagnostic Rating Scales Parent Version has been shown to have valid psychometric 
properties consistent with the Diagnostic and Statistical Manual for Mental Disorders 
Fourth Edition (DSM-IV) diagnosis of ADHD in school-aged children (Wolraich et al., 
2003) and a single parent rater has been successfully used to identify children with 
ADHD in a nationally representative sample (Froehlich et al., 2007).  The Vanderbilt 
includes a 9-item Inattentive Scale, 9-item Hyperactive/Impulsive Scale, 8-item 
Oppositional Defiant Disorder Scale, 14-item Conduct Disorder Scale, and 7-item 
Anxiety/Depression Scale.  The Total ADHD Symptom Score (18 items), is a summary 
score of the Inattentive Scale and Hyperactive/Impulsive Scale.  The Vanderbilt scales 
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use a 4-point Likert rating, in which the parent notes whether over the last 6 months the 
behavior symptoms have occurred rarely, sometimes, often, or very often.   
Demographics. Parents completed the PedsQL™ Family Information Form 
(Varni et al., 2001) which contains demographic information including the child’s date 
of birth, gender, race/ethnicity, and parental education and occupation information 
required to calculate the Hollingshead socioeconomic status (SES) index (Hollingshead, 
1975). 
Disease-Specific Indicators. The following information was retrieved from the 
child’s medical chart by a research nurse: number of months since diagnosis, number of 
diagnoses, category of co-morbid diagnoses, number of daily medications, name of daily 
medications, and number of months on medications.  ADHD and co-morbid psychiatric 
diagnoses were made after an extensive clinical interview by a child psychiatrist prior to 
the child being enrolled in the study based on signs and symptoms presented and history, 
including in some cases diagnostic scales completed by parents and teachers.    
Procedures 
Data collection took place over a three year period between 2005 and 2008.  
Children ages 5-18 and their parents were given a specific PedsQL™ Generic Core 
Scales age-appropriate form depending on the child’s age (5-7, 8-12, and 13-18).  
Younger children (5-7 years) were assisted by a research assistant in completing the 
measure.  The research assistant was also present to assist children in the older groups 
and parents as needed.  Parents then completed the PedsQL™ Family Impact Module, 
Vanderbilt ADHD Diagnostic Rating Scales Parent Version, and the PedsQL™ Family 
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Information Form, in that order.  Instruments were completed by participants in a patient 
examination room in the Pediatric Psychiatric Clinic, either while waiting for the 
physician or after the child’s appointment with the physician.  A $10 gift certificate was 
provided to each child/parent pair for their participation in the study.  Written parental 
informed consent and child assent were obtained.  This research protocol was approved 
by the Institutional Review Board at Scott & White Memorial Hospital and Clinics. 
Statistical Analyses  
First, independent samples t tests to compare pediatric patients with ADHD and a 
matched sample of healthy children on the PedsQL 4.0 Generic Core Scales.  In order 
to determine the magnitude of the differences between pediatric patients with ADHD 
and healthy children, effect sizes were calculated (Cohen, 1988).  Effect size as utilized 
in these analyses were calculated by taking the difference between the healthy sample 
mean and the ADHD sample mean, divided by the pooled standard deviation.  Effect 
sizes for differences in means are designated as small (.20), medium (.50), and large 
(.80) in magnitude (Cohen, 1988).  
To test hypothesis 2, an analysis of Pearson’s Product Moment Correlations 
among the PedsQL™ 4.0 Generic Core Scales and the NICHQ Vanderbilt Total ADHD 
Symptom Score, as well as disease-specific indicators including number of months since 
diagnosis, number of diagnoses, number of daily medications, and number of months on 
medications, were examined.  Pearson’s Product Moment Correlation coefficient effect 
sizes are designated as small (.10-.29), medium (.30-.49), and large (>.50)(Cohen, 1988).  
In addition, to test hypothesis 2, two separate hierarchical linear regression models were 
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constructed to assess the associations between overall HRQOL and ADHD 
symptomatology, over and above the associations between HRQOL, demographic 
variables, and disease-specific indicators.  It was hypothesized that inattentive symptoms 
would be more strongly associated with impairments in HRQOL than 
hyperactive/impulsive symptoms based on previous Pearson Correlation  findings with 
children with ADHD (Gordon et al., 2006; A. F. Klassen et al., 2004).  The block-entry 
method was used with overall generic HRQOL (PedsQL™ Generic Core Total Score for 
child self-report and parent proxy-report) as primary outcomes.  Independent variables 
were entered into the models in blocks in the following order: (1) sociodemographic 
characteristics (age, gender, race/ethnicity, SES); (2) disease-specific indicators (number 
of ADHD medications, time on ADHD medications, time since ADHD diagnosis, 
presence of co-morbid diagnosis, number of diagnoses); and (3) ADHD symptomatology 
(Vanderbilt Inattentive Scale and Vanderbilt Hyperactive/Impulsive Scale).  The order 
for entering independent variables (i.e., entering demographic variables first followed by 
disease-specific indicators and symptoms) was modeled after two previous studies that 
utilized hierarchical linear regression analyses (Bastiaansen, Koot, & Ferdinand, 2005; 
Cotton et al., 2009).  As noted above in the description of the sample, there was some 
missing data with regard to demographic variables and disease-specific indicators.  Since 
these variables were entered into the first and second blocks of the two hierarchical 
linear regression models, cases with missing demographic and disease-specific data were 
excluded from the analyses which resulted in a final sample of 140 for child self-report 
and parent proxy-report.   
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To test hypothesis 3, an analysis of Pearson’s Product Moment Correlations 
among the PedsQL™ Family Impact Module and the NICHQ Vanderbilt Total ADHD 
Symptom Score, as well as disease-specific indicators including number of months since 
diagnosis, number of diagnoses, number of daily medications, and number of months on 
medications, were examined.  An analysis of Pearson’s Product Moment Correlations 
among the PedsQL™ Family Impact Module and PedsQL™ 4.0 Generic Core Scales 
was also conducted.  As previously noted, Pearson’s Product Moment Correlation 
coefficient effect sizes are designated as small (.10-.29), medium (.30-.49), and large 
(>.50)(Cohen, 1988).  In addition, to test hypothesis 3 a separate hierarchical linear 
regression model was constructed to assess the associations between family impact and 
child psychosocial functioning, over and above the associations between family impact, 
demographic variables, and disease-specific indicators/symptom severity.  The block-
entry method was used with overall family impact (PedsQL Family Impact Module 
Total Score) as the primary outcome.  It was hypothesized that child emotional, social, 
and school functioning would be associated with family impact based on previous 
literature (Riley, Lyman et al., 2006; Whalen et al., 2006; B. J. Kaplan et al., 1998).  
Independent variables were entered into the model in blocks in the following order: (1) 
sociodemographic characteristics (age, gender, race/ethnicity, SES); (2) disease-specific 
indicators/symptom severity (number of ADHD medications, time on ADHD 
medications, time since ADHD diagnosis, presence of co-morbid diagnosis, number of 
diagnoses, Vanderbilt ADHD Symptom Score); and (3) child psychosocial functioning 
(parent proxy-reported PedsQL™ Emotional Functioning Scale, PedsQL™ Social 
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Functioning Scale, PedsQL™ School Functioning Scale).  The order for entering 
independent variables (i.e., entering demographic variables first followed by disease-
specific indicators and symptoms) was modeled after two previous studies that utilized 
hierarchical linear regression analyses (Bastiaansen et al., 2005; Cotton et al., 2009).  
There was some missing data with regard to demographic variables and disease-specific 
indicators.  Since these variables were entered into the first and second blocks of the 
hierarchical linear regression model, cases with missing demographic and disease-
specific data were excluded from the analyses which resulted in a final sample of 147.   
Agreement between child self-report and parent proxy-report (hypothesis 4) was 
determined through Intraclass Correlations (ICCs) (McGraw & Wong, 1996).  The ICC 
provides an index of absolute agreement given that it takes into account the ratio 
between subject variability and total variability (Cremeens, Eiser, & Blades, 2006; 
McGraw & Wong, 1996).  Intraclass Correlations are designated as < 0.40 poor to fair 
agreement, 0.41-0.60 moderate agreement, 0.61-0.80 good agreement, and 0.81-1.00 
excellent agreement (Bartko, 1966; Wilson, Dowling, Abdolell, & Tannock, 2001).  In 
addition, mean values between children and parent scores on the PedsQL™ 4.0 Generic 
Core Scales were compared using independent samples t tests.  In order to determine the 
magnitude of the differences between pediatric patients with ADHD and their parents, 
effect sizes were calculated.(Cohen, 1988)  Effect size as utilized in these analyses were 
calculated by taking the difference between the child mean and the parent sample mean, 
divided by the pooled standard deviation.  As previously noted, effect sizes for 
differences in means are designated as small (.20), medium (.50), and large (.80) in 
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magnitude (Cohen, 1988).  Statistical analyses were conducted using SPSS Version 16.0 
for Windows (SPSS, 2008).   
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RESULTS 
Exploratory Age Analysis 
Table 2 presents PedsQL™ 4.0 Generic Core Scale scores across age forms (5-7, 
8-12, 13-18).  For child self-report, statistically significant differences between age 
forms were found on Physical Health and School Functioning.  Specifically, adolescents 
(ages 13-18 years) self-reported significantly better physical health than young children 
(ages 5-7) and children (ages 8-12 years).  Young children self-reported significantly 
better school functioning than children and adolescents.  For parent proxy-report, parents 
of young children (ages 5-7) reported significantly better PedsQL™ Total Scale, 
Psychosocial Health, Social Functioning, and School Functioning scores for their 
children compared to parents of children (ages 8-12).  Despite these significant 
differences, data were pooled across age forms for the subsequent analyses given that 
sample sizes for each age form (n = 46 young child, n = 75 child, n = 60 adolescent) 
were not large enough to conduct separate analyses.  It should be noted that for the 
hierarchical linear regression analyses (hypothesis 2 and 3), age was one of the socio-
demographic variables controlled for in the first block.              
Comparisons between Children with ADHD and Healthy Children 
For pediatric patients with ADHD and healthy children, means and standard 
deviations of the PedsQL™ 4.0 Generic Core Scale Scores for patient self-report and 
parent proxy-report are presented in Table 3.  For all PedsQL™ 4.0 Generic Core Scales, 
pediatric patients with ADHD and their parents reported statistically significant worse 
HRQOL than healthy children.  All effect sizes were in the large range, with the greatest 
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effects for both child self-report and parent proxy-report found on the Psychosocial 
Health Summary Score.    
Intercorrelations with the PedsQL™ 4.0 Generic Core Scales 
Tables 4 and 5 show the intercorrelations among the PedsQL™ 4.0 Generic Core 
Scales, the NICHQ Vanderbilt Total ADHD Symptom Score, and disease-specific 
indicators including number of months since diagnosis, number of diagnoses, number of 
daily medications, and number of months on medications.   
More impaired generic HRQOL was significantly correlated with more severe 
ADHD symptoms as measured by the NICHQ Vanderbilt Total ADHD Symptom Score 
for parent proxy-report (Table 5).  All PedsQL™ 4.0 Generic Scales were significantly 
correlated with the Vanderbilt Total ADHD Symptom Score, with the largest 
intercorrelations demonstrated on Psychosocial Health (-0.56, P<0.001) and School 
Functioning (-0.52, P<0.001).  Pearson’s Product Moment Correlations between the 
PedsQL™ 4.0 Generic Core Scales and Vanderbilt Total ADHD Symptom Score were 
all in the medium to large effect size range.  Number of diagnoses was also significantly 
correlated with all PedsQL™ 4.0 Generic Core Scales, with the largest intercorrelation 
found on Psychosocial Health (-0.33, P<0.001).  Psychosocial Health and School 
Functioning were significantly correlated with number of daily medicines (-0.17, 
P<0.05; -0.17, P<0.05), number of months on medicines (-0.19, P<0.05; -0.19, P<0.05), 
and number of months since diagnosis (-0.19, P<0.05; -0.18, P<0.05).         
For child self-report (Table 4), the intercorrelations between impaired generic 
HRQOL and more severe ADHD symptoms as measured by the NICHQ Vanderbilt 
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Total ADHD Symptom Score were not statistically significant.  The only child self-
report intercorrelation that was significant between the PedsQL™ and Vanderbilt Total 
ADHD Symptom Score was evidenced on the School Functioning Scale (-0.16, P<0.05).  
The PedsQL™ School Functioning Scale was also significantly correlated with number 
of diagnoses (-0.27, P<0.001), number of months on medicines (-0.21, P<0.01), and 
number of months since diagnosis (-0.20, P<0.01).  The PedsQL™ Psychosocial Health 
Summary Score was significantly correlated with number of diagnoses (-0.18, P<0.05).  
All of the child self-report intercorrelations were in the small effect size range (<0.30).         
Hierarchical Multiple Regression Modeling: PedsQL™ 4.0 Generic 
 Table 6 shows the results of the hierarchical linear regression analyses.  Overall 
generic HRQOL was the primary outcome (PedsQL™ Generic Core Total Score for 
child self-report and parent proxy-report).  Standardized betas for the full models (both 
significant and nonsignificant) are presented in Table 6.  The parent proxy-report 
regression model was significant at P<0.001.  The child self-report regression model was 
not statistically significant.  Age was associated with HRQOL for child self-report in 
that older children had better overall HRQOL than younger children.  Socioeconomic 
status was associated with HRQOL for parent proxy-report in that children from higher 
SES families had better overall HRQOL.  Number of diagnoses was also associated with 
HRQOL for parent proxy-report in that children with fewer diagnoses had better overall 
HRQOL.     
 Over and above the association between demographic variables, disease-specific 
indicators, and HRQOL, ADHD symptomatology independently contributed to the 
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variance in both child self-report and parent proxy-report regression models.  For both 
models, inattentive symptoms were significantly associated with overall HRQOL.  
Hyperactive/impulsive symptoms were not significantly associated with overall HRQOL 
in either model.         
Intercorrelations with the PedsQL™ Family Impact Module  
 Table 7 presents intercorrelations among the PedsQL™ Family Impact Module 
and the NICHQ Vanderbilt Total ADHD Symptom Score, as well as disease-specific 
indicators including number of months since diagnosis, number of diagnoses, number of 
daily medications, and number of months on medications.  Greater negative family 
impact was significantly correlated with more severe ADHD symptoms as measured by 
the NICHQ Vanderbilt Total ADHD Symptom Score (Table 7).  All PedsQL™ Family 
Impact Module Scales were significantly correlated with the Vanderbilt Total ADHD 
Symptom Score, with the largest intercorrelations demonstrated on the Total Impact 
Score (-0.50, P<0.0001), Family Summary (-0.51, P<0.0001) and Worry Scale (-0.51, 
P<0.0001).  All Pearson’s Product Moment Correlations between the PedsQL™ Family 
Impact Module  and Vanderbilt Total ADHD Symptom Score were in the large effect 
size range, with the exception of Cognitive Functioning (-0.28, P<0.0001) which was in 
the medium effect size range.  Number of diagnoses was significantly correlated with the 
PedsQL™ Family Impact Module Parent HRQOL Summary (-0.18, P<0.05), Physical 
Functioning (-0.18, P<0.05), Emotional Functioning (-0.16, P<0.05), Social Functioning 
(-0.17, P<0.05), Communication (-0.16, P<0.05), and Family Summary (-0.18, P<0.05).  
Number of daily medications was significantly correlated with the PedsQL™ Family 
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Impact Total Scale Score (-0.16, P<0.05), Parent HRQOL Summary (-0.18, P<0.05), 
Physical Functioning (-0.18, P<0.05), Cognitive Functioning (-0.15, P<0.05), Worry (-
0.15, P<0.05), Family Summary (-0.18, P<0.05), and Daily Activities (-0.19, P<0.05).    
 Tables 8 and 9 present intercorrelations among the PedsQL™ Family Impact 
Module and PedsQL™ 4.0 Generic Core Scales.  More impaired generic HRQOL was 
significantly correlated with more severe family impact for parent proxy-report (Table 
9).  The largest intercorrelations for parent proxy-report were demonstrated between the 
PedsQL™ Family Impact Module Scales and the PedsQL™ Generic Core Psychosocial 
Health Summary Score, with all effect sizes in the medium to large range. 
The majority of intercorrelations between the PedsQL™ Family Impact Module 
and child self-reported PedsQL™ 4.0 Generic Core Scales were not significant (Table 
8).  The PedsQL™ Generic Core Total Scale Score was significantly correlated with 
parent social functioning (0.16, P<0.05); the School Functioning Scale on the PedsQL™ 
Generic Core was significantly correlated with the Family Impact Module Family 
Summary (0.16, P<0.05) and Family Activities Scale (0.17, P<0.05).  All effect sizes 
were in the small range.                  
Hierarchical Multiple Regression Modeling: PedsQL™ Family Impact 
Table 10 presents the results of the hierarchical linear regression analysis.  The 
PedsQL™ Family Impact Module Total Scale Score was the primary outcome.  
Standardized betas for the full model (both significant and nonsignificant) are presented 
in Table 10.  The regression model was significant at P<0.001.  ADHD symptom 
severity was associated with family impact in that families of children with greater 
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ADHD symptom severity had greater negative family impact.  Over and above the 
association between demographic variables, disease-specific indicators/symptom 
severity, and family impact, child social functioning independently contributed to the 
variance in the regression model.  Child emotional and school functioning were not 
significantly associated with the PedsQL™ Family Impact Module Total Score in the 
model.         
Parent/Child Agreement 
Intraclass Correlations (ICC) between pediatric patient self-report and parent 
proxy-report across the PedsQL™ 4.0 Generic Core Scales are as follows: Total Score = 
0.24 (P<0.0001), Physical Health = 0.13 (P<0.05), Psychosocial Health = 0.30 
(P<0.0001), Emotional Functioning = 0.19 (P<0.001), Social Functioning = 0.29 
(P<0.0001), School Functioning = 0.35 (P<0.0001).  These ICCs are in the poor to fair 
agreement range.  The greatest agreement was found between children and parents on 
School Functioning while the lowest agreement was demonstrated between children and 
their parents on Physical Health.       
Mean scores for the 177 parents and children who both completed the PedsQL™ 
4.0 Generic Core Scales are presented in Table 11.  Across all PedsQL™ Scales, 
children self-reported significantly higher HRQOL than their parents, with the greatest 
differences evidenced on School Functioning (effect size = 0.61) and Psychosocial 
Health (effect size = 0.57).      
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DISCUSSION AND CONCLUSIONS   
The aim of the current study was to assess HRQOL from the perspective of 
pediatric patient self-report and parent proxy-report and family impact from the 
perspective of parents in children with ADHD ages 5 to 18 years being seen at a 
Pediatric Psychiatric Clinic.  Consistent with previous PedsQL™ findings utilizing child 
self-report and parent proxy-report in a population-based study (Varni & Burwinkle, 
2006) of children with ADHD and findings utilizing other HRQOL proxy-report 
measures in this population (A. F. Klassen et al., 2004; Matza et al., 2004), children with 
ADHD in our sample demonstrated significantly lower HRQOL than a matched sample 
of healthy children for both child self-report and parent proxy-report, with the greatest 
differences demonstrated on psychosocial functioning.  All effect sizes were in the large 
range.   
While we found large effect sizes between pediatric patients with ADHD and 
healthy children on physical functioning, previous studies have reported small effect 
sizes between children with ADHD and healthy children on this domain (A. F. Klassen 
et al., 2004; Varni & Burwinkle, 2006).  This finding may in part be attributed to 
differences in symptom severity between our sample and the samples in Varni & 
Burwinkle (2006) and Klassen et al. (2004).  Our sample consisted of children with 
ADHD and a high incidence of co-morbid psychiatric conditions being treated at a 
Psychiatric Clinic (98.4% of children were taking at least one daily medication to treat 
ADHD symptoms).  Children with ADHD in Varni & Burwinkle were from a 
population-based sample (co-morbid diagnoses and medication use were unknown).  
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Children from Klassen et al. were from an ADHD Clinic; however, according to the 
authors, one-third of the sample was newly identified by family doctors and not 
necessarily complex (only 27.5% of children in the sample were on ADHD 
medications).  There is literature that has shown after adjusting for measures of global 
disadvantage (i.e., poverty, caretaker’s education, parental marital status, number of 
diagnoses other than ADHD) the correlation between ADHD and physical health 
problems was significant for children with ADHD seen in treatment facilities 
(Bauermeister et al., 2007).  This may in part be attributed to the fact that children with 
ADHD seen in treatment facilities are often treated with stimulant medications which 
can have side effects that impact physical functioning (i.e., loss of appetite, headaches, 
stomachaches).  Furthermore, children with ADHD seen in treatment facilities are more 
likely to have co-morbid psychiatric conditions such as depression and anxiety that have 
known physical effects including fatigue and pain (Walford, Nelson, & McCluskey, 
1993).  Thus, our finding that children with ADHD and healthy children evidenced large 
effect sizes on physical functioning from the perspective of both children and parents 
may in part be a function of the more severe nature of our sample.   
Consistent with our hypothesis, more impaired generic HRQOL was significantly 
correlated with more severe ADHD symptomatology for parent proxy-report based on 
Pearson Correlation analyses.  All parent proxy-reported PedsQL™ 4.0 Generic Scales 
were significantly correlated with the Vanderbilt Total ADHD Symptom Score, with the 
largest intercorrelations demonstrated on Psychosocial Health and School Functioning.  
Pearson’s Product Moment Correlations between the PedsQL™ 4.0 Generic Core Scales 
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and Vanderbilt Total ADHD Symptom Score were all in the medium to large effect size 
range for parent proxy-report.  Number of diagnoses was also significantly correlated 
with all parent proxy-reported PedsQL™ 4.0 Generic Core Scales, with the largest 
intercorrelation evidenced on Psychosocial Health.  These findings suggest that from the 
perspective of parents, the severity of the child’s ADHD symptoms and the number of 
diagnoses significantly impact the child’s overall HRQOL, particularly with regard to 
psychosocial functioning.     
Our hypothesis that more impaired generic HRQOL would be significantly 
correlated with more severe ADHD symptomatology was not supported for child self-
report based on Pearson Correlation analyses.  Significant intercorrelations between 
child self-reported PedsQL™ 4.0 Scales and the NICHQ Vanderbilt Total ADHD 
Symptom Score were found only on the PedsQL™ School Functioning Scale.  For child 
self-report, the PedsQL™ School Functioning Scale was also significantly correlated 
with number of diagnoses, number of months on medicines, and number of months since 
diagnosis.  These findings indicate that the severity of a child’s ADHD symptoms (as 
reported by parents), number of diagnoses, number of months on medicines, and number 
of months since diagnosis are significantly associated with the child’s perception of 
his/her school functioning.  The finding that only one child self-reported PedsQL™ 
Scale (School Functioning) was significantly correlated with the Vanderbilt Total 
ADHD Symptom Score (compared to all parent proxy-reported PedsQL™ Scales) may 
in part be a function of the shared method of variance.  That is, parents completed both 
the Vanderbilt Rating Scale and PedsQL™ 4.0 Generic Core parent proxy version.  The 
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differences in the current study between children and parents’ perceptions of the child’s 
HRQOL suggest that children and parents may also have differences in their perceptions 
of the child’s ADHD symptomatology.  Thus, the small effect sizes and lack of 
significant intercorrelations between child self-reported PedsQL™ Generic Core Scales 
and the Vanderbilt Total ADHD Symptom Score may in part be a function of differences 
in child and parent perceptions of the child’s ADHD symptom severity. 
Results of the hierarchical linear regression analyses indicated that over and 
above the association between demographic variables, disease-specific indicators, and 
HRQOL, inattentive symptoms were significantly associated with overall HRQOL for 
both child self-report and parent proxy-report.  Hyperactive/impulsive symptoms were 
not significantly associated with overall HRQOL in either model.  It has been suggested 
that inattentive symptoms related to ADHD may contribute to poor self-observation and 
consequently impact one’s perception of their HRQOL (Lenard et al., 2006).  However, 
our findings held true for both child self-report and parent proxy-report.  In fact, there 
was a stronger association between inattentive symptoms and overall HRQOL for parent 
proxy-report.  Nonetheless, our findings suggest that in children with ADHD and co-
morbid psychiatric conditions, inattentive symptoms may be a strong marker of 
impairment in daily functioning.   
Consistent with our hypothesis, more severe ADHD symptomatology (as 
measured by the NICHQ Vanderbilt Total ADHD Symptom Score) was significantly 
associated with greater negative family impact based on Pearson Correlation analyses.  
All PedsQL™ Family Impact Module Scales were significantly correlated with the 
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Vanderbilt Total ADHD Symptom Score, with the largest intercorrelations demonstrated 
on the Total Impact Score, Family Summary, and Worry Scale.  All Pearson’s Product 
Moment Correlations were in the large effect size range, with the exception of Cognitive 
Functioning.  These findings suggest that greater ADHD symptoms are significantly 
associated with greater parental worry, greater disruptions in family relationships, and 
greater disruption of daily family activities.  Number of diagnoses was also significantly 
correlated with the physical, emotional, and social functioning of parents and family 
communication.  Number of daily medications was significantly correlated with the 
physical and cognitive functioning of parents, parental worry, and daily family activities; 
more medications taken by the child was associated with more negative impact.  This 
finding is consistent with previous literature that suggests demands related to the 
delivery and management of the child’s ADHD medication can negatively impact family 
functioning (Riley, Lyman et al., 2006; Whalen et al., 2006).     
 Consistent with our hypothesis, more impaired generic HRQOL was significantly 
correlated with more negative family impact for parent proxy-report based on Pearson 
Correlation analyses.  The largest intercorrelations for parent proxy-report were 
demonstrated between the PedsQL™ Family Impact Module Scales and the PedsQL™ 
Generic Core Psychosocial Health Summary Score, with all effect sizes in the medium 
to large range.  These findings indicate that from the perspective of parents, impairments 
in the child’s psychosocial functioning are significantly associated with more negative 
family impact.  Our hypothesis was not supported for child self-report in that the 
majority of Pearson Correlations between the PedsQL™ Family Impact Module and 
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child self-reported PedsQL™ 4.0 Generic Core Scales were not significant (all effect 
sizes were in the small range).  Differences in the magnitude of intercorrelations 
between the PedsQL™ Family Impact Module and PedsQL™ Generic Core Scales 
across child self-report and parent proxy-report may be a function of the shared method 
of variance.  Children and parents may have different perceptions of family impact.  The 
current study only assessed family impact from the perspective of parents.     
 Results of the hierarchical linear regression analyses indicated over and above 
the association between demographic variables, disease-specific indicators/symptom 
severity, and family impact, child social functioning was significantly associated with 
the PedsQL™ Family Impact Module Total Score.  Child emotional and school 
functioning were not significantly associated with the PedsQL™ Family Impact Module 
Total Score in the model.  ADHD symptom severity was associated with family impact 
in that families of children with greater ADHD symptom severity had greater negative 
family impact.  The regression model was significant at P<0.001.   
While we hypothesized that children and their parents would demonstrate 
moderate to good agreement regarding the child’s HRQOL as evidenced by Intraclass 
Correlations between 0.41 to 0.80, this hypothesis was not supported.  In the present 
study, Intraclass Correlations between pediatric patient self-report and parent proxy-
report across the PedsQL™ 4.0 Generic Core Scales ranged from 0.13 to 0.35, 
corresponding to the poor to fair agreement range.  Greatest agreement was found 
between children and parents on school functioning while the lowest agreement was 
demonstrated between children and parents on physical health.  Consistent with our 
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hypothesis, across all PedsQL™ Generic Core Scales parents reported significantly 
lower HRQOL for their children when compared to children.  Taken as a whole, these 
findings are consistent with both the adult and pediatric literature, suggesting 
information provided by proxy-respondents is not equivalent to that reported by the 
patient (Achenbach, McConaughy, & Howell, 1987; Sprangers & Aaronson, 1992).  
Imperfect agreement between self-report and proxy-report has been consistently 
documented in the HRQOL measurement of children with and without chronic illness 
(Eiser & Morse, 2001a; Upton et al., 2008), particularly for less observable or internal 
symptoms such as HRQOL.   
Results of our hierarchical linear regression analyses indicated age was 
significantly associated with HRQOL for child self-report in that older children had 
better overall HRQOL than younger children.  When examining mean PedsQL™ 4.0 
Generic Core Scale Scores across age forms (5-7, 8-12, 13-18), we found statistically 
significant differences for both child self-report and parent proxy-report.  Adolescents 
(ages 13-18 years) self-reported significantly better physical health than young children 
(ages 5-7) and children (ages 8-12 years).  Young children self-reported significantly 
better school functioning than children and adolescents.  For parent proxy-report, parents 
of young children (ages 5-7) reported significantly better PedsQL™ Total Scale, 
Psychosocial Health, Social Functioning, and School Functioning mean scores for their 
children compared to parents of children (ages 8-12).  These differences across age 
groups may in part be a function of variations in how ADHD symptoms are manifested 
across childhood.  For example, there is literature that suggests inattentive symptoms are 
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more common among adolescents while hyperactive/impulsive symptoms are more 
common among preschool children (Nolan, Gadow, & Sprafkin, 2001).  In addition, the 
present findings may also reflect differences in demands placed on children of varying 
ages.  For example, in the present study parents of young children (ages 5-7) reported 
better psychosocial health, social functioning, and school functioning mean scores for 
their children compared to parents of older children (ages 8-12).  This finding may in 
part be a function of 8-12 year olds having increasing demands placed on them at home 
and school which may have a negative impact on their daily functioning.   
Limitations 
The present study has a number of potential limitations.  Despite the significant 
differences we found across age forms on the PedsQL™ 4.0 Generic Core Scales, data 
were pooled across age forms for the larger analyses given that sample sizes for each age 
form were not large enough to conduct separate analyses.  Furthermore, there was 
variability within our sample with regard to disease-specific indicators such as time 
since diagnosis and time on medications.  While the heterogeneity of the sample may 
reduce internal validity, these differences also may increase the generalizability of the 
findings.  There was no standardized protocol for diagnosing a child with ADHD or co-
morbid psychiatric conditions in the present study.  However, ADHD and co-morbid 
psychiatric diagnoses were made by a  child psychiatrist prior to the child being enrolled 
in the study based on signs and symptoms presented and history, including in some cases 
diagnostic scales completed by parents and teachers.  We did not have information on 
the exact co-morbid psychiatric conditions children in our sample had, but rather the 
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diagnostic category.  Information on nonparticipants was not available and for the 
hierarchical linear regression analyses, we had to exclude some participants based on 
missing data which may limit the generalizability of the findings.  Our sample was 
predominantly white males, which may further limit the generalizability of the findings.  
However, it should be noted that our sample was representative of the underlying 
population of children with ADHD in the United States which is more likely to be white 
males (Bimstein et al., 2008).  This was a cross-sectional study, thus, it provided only a 
snapshot of HRQOL and family impact at one time point.  Finally, ADHD symptom 
severity and family impact were measured only from the perspective of parents in the 
present study.        
Implications for Future Research and Clinical Practice 
These findings have several implications for future research and clinical practice 
with pediatric patients with ADHD and co-morbid psychiatric conditions and their 
families.  First, given the large effect sizes reported between our sample and healthy 
children on physical functioning, it is important that interventions designed for children 
with ADHD and co-morbid psychiatric conditions not only address psychosocial 
difficulties, but also the physical impairments that may result from medications and/or 
co-morbid psychiatric diagnoses such as anxiety or depression.  A post-hoc analyses of 
responses to individual items on the PedsQL™ Physical Functioning Scale in the current 
sample revealed that 11.7% of the children self-reported “often” or “almost always” 
having low energy, while 14.5% of the children self-reported “often” or “almost always” 
having hurts or aches; 19.9% of  parents reported  their child “often” or “almost always” 
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had low energy, while 26.5% of parents reported their child “often” or “almost always” 
had hurts or aches.  These findings suggest that the constructs of fatigue and pain may be 
important to address in future interventions with this population.  It will be beneficial for 
future research to elucidate the relationship between fatigue, pain, and HRQOL so that 
more efficacious interventions can be developed.  Given the growing body of literature 
that suggests children with ADHD experience chronic sleep difficulties (Lim et al., 
2008),  future research should also investigate the relationship between sleep deficits and 
physical functioning in children with ADHD and co-morbid psychiatric conditions.       
Given our finding that greater ADHD symptomatology was significantly 
associated with greater negative family impact, interventions for this population should 
also focus on mitigating the negative impact of ADHD and co-morbid psychiatric 
conditions on families.  Our  Pearson Correlation analyses suggest that parental worry 
(i.e., worrying about whether or not my child’s medical treatments are working, 
worrying about the side effects of my child’s medications/medical treatments, worrying 
about how others will react to my child’s condition, worrying about how my child’s 
illness is affecting other family members, worrying about my child’s future), family 
relationships (i.e., lack of communication between family members, conflicts between 
family members, difficulty making decisions together as a family, difficulty solving 
family problems together, stress or tension between family members), and daily family 
activities (i.e., family activities taking more time and effort, difficulty finding time to 
finish household tasks, feeling too tired to finish household tasks) may be key areas to 
address in an intervention.  Our hierarchical regression analysis suggested that from the 
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perspective of parents, child social functioning may have the strongest association with 
family impact.  As such, it does not seem sufficient for interventions to only address 
social functioning with the child.  Teaching parents strategies for coping with their 
child’s social impairments will be important.  Given that number of daily medications 
was significantly correlated with the physical and cognitive functioning of parents, 
parental worry, and daily family activities, interventions should also focus on teaching 
parents strategies for coping with the demands related to the delivery and management 
of their child’s ADHD medication regimen.   
Our Pearson Correlation finding that the PedsQL™ School Functioning Scale 
was the only significantly correlated PedsQL™ Scale with the Vanderbilt Total ADHD 
Symptom Score for child self-report (compared to all parent proxy-reported PedsQL™ 
Scales) suggests that from the perspective of children with ADHD and co-morbid 
psychiatric conditions, school functioning is a particularly salient domain.  This finding 
also indicates that future research should assess ADHD symptom severity not only from 
the perspective of parents, but also from the perspective of children, as these different 
perspectives may provide unique information.  Assessing ADHD symptomatology from 
the perspective of other informants such as teachers and healthcare providers may 
provide valuable information as well.  Given the small magnitude of the intercorrelations 
between the PedsQL™ Family Impact Module and child self-reported PedsQL™ 4.0 
Generic Core Scales, future research should establish the reliability and validity of 
measures of family impact that evaluate the perspectives of older children and 
adolescents in order that their perspectives be included in future clinical trials.    
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Our findings demonstrate the importance of including HRQOL as a 
multidimensional outcome in future clinical trials (Wigal et al., 2005; Sallee, Ambrosini, 
Lopez, Shi, & Michaels, 2004).   The data suggest that improvements in a child’s ADHD 
symptomatology should be associated with improvements in the child’s overall HRQOL.  
While previous Pearson Correlation studies indicate inattentive symptoms are more 
strongly associated with impairments in HRQOL and daily functioning than 
hyperactive/impulsive symptoms in children with ADHD (Gordon et al., 2006; A. F. 
Klassen et al., 2004), to the best of our knowledge this is the first study to use 
hierarchical linear regression analyses to assess the associations between HRQOL, 
inattentive symptoms, and hyperactive/impulsive symptoms over and above the 
associations between demographic variables, disease-specific indicators, and HRQOL.  
While the focus of these analyses was on ADHD symptomatology, future studies should 
use hierarchical linear regression analyses to assess the associations between HRQOL 
and symptoms related to co-morbid psychiatric conditions such as anxiety, depression 
and conduct problems.        
The finding that children and their parents demonstrated poor to fair agreement 
regarding the child’s HRQOL underscores the importance of  evaluating both children’s 
and parents’ perspectives regarding HRQOL in routine assessment in clinical practice 
and clinical trials for children with ADHD and co-morbid psychiatric conditions since 
their different perspectives potentially provide unique information.  Discrepancies 
between child and parent reports of the child’s HRQOL can be used clinically to 
facilitate communication between parents and children.  For example, if a child reports 
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that “almost always” other kids tease him/her and his mother reports that the child 
“never” gets teased by other children, this would be an opportunity for the child’s 
healthcare provider to intervene and discuss these differences in perspective with the 
child and parent.  A number of studies with children with chronic health conditions have 
reported greater agreement between parents and children on physical functioning since 
this is a more observable construct (Eiser & Morse, 2001b).  The finding that agreement 
was lowest between parents and children on physical functioning in our sample further 
demonstrates the need for future research to investigate the construct of physical 
functioning in children with ADHD and co-morbid psychiatric conditions.  Future 
studies should evaluate factors that influence parent-child agreement in this population.  
For example, one recent study with children with ADHD utilizing the Child Health 
Questionnaire found that parent-child agreement was related to the presence of co-
morbid oppositional/defiant disorder, a psychosocial stressor, and increased ADHD 
symptomatology (A. Klassen, Miller, & Fine, 2006).  Other variables that may be 
important to evaluate in future research include SES, child age, and treatment setting.           
 The age differences reported in this study on the PedsQL™ 4.0 Generic Core 
Scales, and the literature that indicates ADHD symptoms may be manifested differently 
across childhood (Nolan et al., 2001), have implications for how interventions are 
designed for children with ADHD and co-morbid psychiatric conditions.  For example, 
our study suggests that from the perspective of children, impairments in physical 
functioning may be especially important to address in young children (ages 5-7) and 
children (ages 8-12 years); difficulties related to school may be more important to 
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address in older children and adolescents than young children.  From the perspective of 
parents, issues related to social and school functioning may be important to address in 
older children.  Future studies should evaluate HRQOL across individual age groups 
with sufficient sample sizes in order to determine the impact of age on ADHD 
symptomatology and HRQOL.  Given that our study was cross-sectional, and provided a 
snapshot of HRQOL and family impact at one time point, longitudinal studies of 
HRQOL and family impact should be conducted with this population.   
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APPENDIX  
TABLES  
 
Table 1.  Studies Assessing Health-Related Quality of Life in Children with Attention-
Deficit/ Hyperactivity Disorder 
 
Study Sample HRQOL Outcome Key Findings 
Varni & 
Burwinkle 
(2006) 
72 children identified 
by their parents as 
having ADHD ages 
5-16 years 
PedsQL™ 4.0 Generic 
Core Scales Child Self-
Report and Parent 
Proxy-Report 
PedsQL™ 
evidenced minimal 
missing responses 
for child self-
report (0.0%) and 
parent proxy-
report (4.9%), 
demonstrated 
excellent 
reliability for the 
Total Scale Score 
for child self-
report 
(alpha=0.92) and 
parent proxy-
report 
(alpha=0.92), and 
discriminated 
between children 
with ADHD and  a 
matched sample of 
healthy children 
with the greatest 
differences 
evidenced in 
psychosocial 
functioning 
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Matza et al. 
(2004) 
297 children who 
met DSM-IV criteria 
for ADHD by 
clinical assessment 
and structured 
interview ages 8-17 
years   
Child Health 
Questionnaire (CHQ) 
Parent Form 
The CHQ Parent 
scores on 
psychosocial 
scales lower than 
physical scales, 
CHQ psychosocial 
scales significantly 
negatively 
correlated with 
measures of 
ADHD symptom 
severity but in 
general CHQ 
physical scales 
were not, 
significant 
differences 
between the 3 
symptom severity 
groups were 
demonstrated on 
CHQ, and 
improvements in 
ADHD symptoms 
over time were 
associated with 
improvements in  
CHQ psychosocial 
scales   
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Sallee et al. 
(2004) 
2,968 children who 
met DSM-IV criteria 
for a primary 
diagnosis of ADHD 
ages 6-12 years 
PedsQL™ 4.0 Generic 
Core Scales Parent 
Proxy-Report 
In this 
prospective,open-
label study, 
baseline 
immediate-release 
stimulants 
(Adderall or 
Concerta) were 
converted to 
approximately 
equivalent once-
daily dose 
(extended release) 
Adderall; Mean 
PedsQL™ Total 
Score at baseline 
was 74.5 
compared to 81.0 
after 7 weeks of 
treatment 
(p<.0001)   
Bastiaens 
(2008) 
84 children ages 5-
18 years diagnosed 
with ADHD  
Health and Life 
Functioning Scale 
Parent Proxy-Report 
In this prospective, 
nonrandomized 
comparison 
between children 
with ADHD 
treated with 
atomexetine or 
stimulants, no 
significant 
differences in 
improvements in 
quality of life were 
reported between 
the 2 groups after 
8 months of 
treatment 
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Riley et al. 
(2006) 
1,477 children 
diagnosed with 
ADHD ages 6-18 
years  
Child Health and Illness 
Profile (CHIP) Parent 
Proxy-Report 
Cronbach’s alphas 
were all above 
0.70 for the CHIP 
scales, no ceiling 
or floor effects 
were reported, 
moderate to high 
correlations were 
observed between 
the CHIP and 
ADHD symptoms 
and family factors, 
scores on the 
CHIP for children 
with ADHD were 
2 standard 
deviations below 
community norms   
Sawyer et al. 
(2002) 
308 children ages 6-
17 years identified as 
having ADHD 
through the parent 
version of the DISC-
IV  
Child Health 
Questionnaire (CHQ) 
Parent Form 
Children with 
ADHD were 
compared to a 
sample of children 
with Major 
Depressive 
Disorder and a 
sample of children 
with Conduct 
Disorder; children 
with ADHD had 
significantly more 
behavioral 
problems and 
significantly fewer 
emotional 
problems than 
children with 
Major Depressive 
Disorder. 
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Perwien et al. 
(2004) 
877 children who 
met DSM-IV criteria 
for ADHD ages 6-17 
years 
Child Health 
Questionnaire (CHQ) 
Parent Form 
Children who 
received 
atomoxetine had 
significantly 
greater 
improvement in 
psychosocial 
functioning 
compared to 
placebo group; no 
significant 
differences were 
found between 
once-a-day and 
twice-a-day 
dosing; treatment 
with atomoxetine, 
lower HRQOL 
baseline scores, no 
history of 
stimulant use, and 
absence of 
oppositional 
defiant disorder 
were associated 
with 
improvements in 
psychosocial 
functioning 
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Sung et al. 
2008 
239 children 
diagnosed by a 
clinician with ADHD 
ages 5-18 years 
PedsQL™ 4.0 
Generic Core Scales 
Parent Proxy-Report 
Children with mild 
and moderate or 
severe sleep 
problems had 
significantly lower 
PedsQL™ Total and 
Psychosocial scores 
than those without 
sleep problems; 
severity of ADHD 
symptoms was 
strongly associated 
with both moderate 
and or severe sleep 
problems and the 
Physical Functioning 
scale on the 
PedsQL™   
Klassen et al. 
(2004) 
131 children with a 
physician diagnosis 
of ADHD ages 6-17 
years   
Child Health 
Questionnaire (CHQ) 
Parent Form 
Children with 
ADHD had 
comparable physical 
health to the 
population norms 
but clinically 
important deficits in 
HRQOL in all 
psychosocial 
domains; poorer 
HRQOL for all 
domains of 
psychosocial health 
correlated 
significantly with 
more parent-reported 
inattentive, 
hyperactive, and 
combined symptoms 
of ADHD 
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Yang et al. 
(2007) 
119 children who 
met DSM-IV criteria 
for ADHD currently 
receiving 
methylphenidate 
treatment ages 6-15 
years 
Child Health 
Questionnaire (CHQ) 
Parent Form 
HRQOL of 
children with 
ADHD was 
reported to be 
significantly worse 
than the healthy 
control group on 
all CHQ 
psychosocial 
scales; the 
Psychosocial 
Summary Score 
increased with 
improvement of 
clinical symptoms 
after 
methylphenidate 
treatment 
Svanborg et 
al. (In press) 
99 patients 
diagnosed with 
ADHD receiving 
either atomoxetine (n 
= 49) or placebo (n = 
50)  
 
Child Health and Illness 
Profile-Child Edition 
(CHIP-CE) 
A statistically 
significant 
difference in favor 
of atomoxetine 
was seen in the 
improvement from 
baseline to study 
endpoint for the 
CHIP-CE domains 
‘‘Achievement’’ 
and ‘‘Risk 
Avoidance.’’ 
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Table 1 continued 
Study Sample HRQOL Outcome Key Findings 
Wigal et al., 
2005 
215 subjects ages 6 
to 12 years with 
ADHD were enrolled 
in the study;  107 
subjects were 
randomized to 
receive MAS XR 
and 108 subjects 
were randomized to 
receive 
atomoxetine 
PedsQL™ 4.0 Generic 
Core Scales Parent 
Proxy-Report 
The mean PedsQL 
total score 
increases of 7.1 
unit points in the 
MAS XR group 
and 7.9 
unit points in the 
atomoxetine group 
represent 
statistically 
significant 
improvements 
compared with 
baseline 
scores, but the 
difference between 
medication 
effects was not 
statistically 
significant. The 
PedsQL school 
functioning score 
was the only 
subscale score for 
which a 
statistically 
significant 
treatment effect 
was observed. The 
34% improvement 
in 
the PedsQL school 
functioning 
subscale in the 
MAS XR 
group was larger 
than the 25% 
improvement in 
the 
atomoxetine group 
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Table 2. PedsQL™ 4.0 Generic Core Scales Scores across Age Forms   
 
 Age Form 
Scale Young Child  
(5-7 years) a 
Child  
(8-12 years) b 
Teen  
(13-18 years) c 
 n Mean SD n Mean SD n Me
an 
SD 
Child Self-Report           
  Total Score 46 66.17 17.36 73 64.88 15.57 60 70.2
3 
14.5
0   Physical Health 46 71.74 17.86 73 73.80 18.71 60 83.7
0 
13.6
0   Psychosocial    
  Health 
46 63.19 20.18 73 60.10 16.59 60 63.0
8 
16.7
0 
  Emotional   
  Functioning 
46 58.26 27.97 73 57.95 21.10 60 61.3
3 
22.5
1 
  Social Functioning 46 63.04 28.27 73 64.57 24.19 60 72.1
9 
22.2
4   School Functioning 46 69.33 22.30 73 57.71 19.65 60 55.7
5 
18.2
5 Parent Proxy-
Report 
         
  Total Score 46 63.07 16.29 75 55.03 17.48 60 58.9
6 
19.3
8   Physical Health 46 74.85 23.03 75 69.17 25.26 60 69.6
3 
24.4
8   Psychosocial Health 46 56.72 17.00 75 47.50 16.47 60 53.2
7 
19.2
0   Emotional   
  Functioning 
46 49.46 21.17 75 44.85 18.31 60 51.9
2 
21.8
3 
  Social Functioning 46 66.74 19.67 75 54.93 21.77 60 57.7
7 
25.5
0   School Functioning 46 54.00 19.73 75 42.73 19.00 60 50.0
8 
18.2
1  
Note: Higher values equal better health-related quality of life. 
Comparisons based on Tukey HSD Post-hoc analysis (ANOVA). 
Child Self-Report Physical Health c>a,b, p<.05; Child Self-Report School Functioning     
a>b,c, p<.05.  
Parent Proxy-Report Total Score, Psychosocial Health, Social Functioning, and School 
Functioning, a>b, p<.05.  
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Table 3.  PedsQL 4.0 Generic Core Scales for Child Self-Report and Parent Proxy- 
Report across Samples and Reliability for ADHD Sample  
 
 
ADHD 
  
Healthy 
  
Differences 
 
Effect 
Size 
Scale α Mean  SD  Mean SD     
Child Self-Report 
(n = 179)  (n =876)    
Total Score 0.85 67.00 15.80  85.86 11.76  18.86*** 1.50 
Physical Health 0.71 76.59 17.60  90.09 11.58  13.50*** 1.05 
Psychosocial Health 0.81 61.89 17.57  83.62 13.47  21.73*** 1.53 
Emotional 
Functioning 
0.72 59.16 23.41  81.99 17.16  22.83*** 1.24 
Social Functioning 0.75 66.73 24.86  87.25 15.63  20.52*** 1.17 
School Functioning  0.65 59.99 20.55  81.66 15.92  21.67*** 1.29 
Parent Proxy-
Report  
(n = 181)  (n =1443)    
Total Score 0.92 58.38 18.04  86.04 12.72  27.66*** 2.06 
Physical Health 0.89 70.77 24.44  89.33 15.20  18.56*** 1.13 
Psychosocial Health 0.90 51.76 17.87  84.19 13.45  32.43*** 2.31 
Emotional 
Functioning 
0.79 48.36 20.39  82.39 15.88  34.03*** 2.07 
Social Functioning 0.85 58.87 22.96  88.01 15.58  29.14*** 1.76 
School Functioning  0.78 48.00 19.40  81.41 17.61  33.41*** 1.88 
 
Note: ***p<.001 based on independent samples t tests. 
α = Cronbach internal consistency reliability coefficient alpha.   
SD = standard deviation.  
Effect sizes are designated as small (.20), medium (.50), and large (.80).  
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Table 4. Intercorrelations among PedsQL™ 4.0 Generic Core Scales and Disease-Specific 
 Indicators of ADHD for Child Self-Report 
  
 
Note: *p<.05, **p<.01, ***p<.001.    
Effect sizes are designated as small (0.10), medium (0.30), and large (0.50) for Pearson’s 
product moment correlations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Child Self-Report  
 
 
PedsQL™ Scales 
Vanderbi
lt ADHD 
Sympto
m Score 
Vanderbi
lt 
Inattentiv
e 
Scale 
Vanderbil
t 
Hyperacti
ve-
Impulsive 
Scale 
Number 
of 
Diagnose
s 
Numbe
r of 
Daily 
Medici
nes 
Number 
of 
Months 
on 
Medicin
es 
Number 
of 
Months 
since 
Diagnosi
s 
   Total Score -0.12 -0.16* -0.09 -0.12 -0.02 -0.05 -0.05 
   Physical Health -0.04 -0.06 -0.01  0.03 0.05 0.07 0.08 
   Psychosocial 
Health 
-0.15 -0.19* -0.13  -0.18* -0.06 -0.11 -0.10 
   Emotional 
Functioning 
-0.04 -0.07 -0.04 -0.07 -0.03 -0.06 -0.07 
   Soc al 
Functioning 
-0.13 -0.09 -0.16* -0.12 -0.03 -0.02 0.00 
   School 
Functioning 
 -0.16* -0.29*** -0.07 -0.27*** -0.08   -
0.21** 
  -0.20** 
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Table 5. Intercorrelations among PedsQL™ 4.0 Generic Core Scales and Disease-Specific  
Indicators of ADHD for Parent Proxy-Report 
  
 
 
 
 
 
Parent Proxy-Report  
 
 
PedsQL™ 
Scales 
Vanderbil
t ADHD 
Symptom 
Score 
Vanderbi
lt 
Inattentiv
e 
Scale 
Vanderbilt 
Hyperactiv
e-
Impulsive 
Scale 
Number 
of 
Diagnoses 
Number 
of Daily 
Medicine
s 
Number 
of Months 
on 
Medicines 
Numb
er of 
Month
s since 
Diagn
osis 
   Total Score -0.51*** -0.55*** -0.37***   -0.31*** -0.09   -0.19*    -
0.19* 
   Physical 
Health 
-0.33*** -0.37*** -0.24** -0.21**  0.04 -0.13   -0.14 
   Psychosocial 
Health 
-0.56*** -0.59*** -0.40***   -0.33***   -0.17*  -0.19*   -
0.19* 
   Emotional 
Functioning 
-0.48*** -0.47*** -0.39***   -0.27***    -0.20** -0.10 -0.12 
   Soc al 
Functioning 
-0.44*** -0.45*** -0.34***   -0.29*** -0.06    -0.20**  -0.19* 
   School 
Functioning 
-0.52*** -0.61*** -0.31***   -0.28***   -0.17*   -0.19* -0.18* 
 
Note: *p<.05, **p<.01, ***p<.001.    
Effect sizes are designated as small (0.10), medium (0.30), and large (0.50) for Pearson’s 
product moment correlations. 
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                   Table 6. Hierarchical Linear Regression Models for Factors Associated with HRQOL 
 
Variables PedsQL™ Core 
Total Scale Score 
Child Self-Report 
PedsQL™ Core 
Total Scale Score 
Parent Proxy-
Block 1 (demographic variables)  
 
  R
 2 0.03 0.04 
  Gender             -0.04 -0.08 
  Race/Ethnicity  0.04 0.04 
  Socioeconomic Status 0.00  0.14* 
  Age  0.24* -0.02 
Block 2 (disease-specific 
indicators) 
  
  R
 2 change 0.05     0.17*** 
  Number of daily ADHD 
medications 
0.09 0.04 
  Months on daily ADHD 
medications 
            -0.29 0.15 
  Months since ADHD Diagnosis 0.08 -0.30 
  Presence of Co-Morbid Diagnosis 0.15 0.12 
  Number of Diagnoses -0.08 -0.24* 
Block 3 (ADHD 
Symptomatology) 
  
  R
 2 change  0.05*     0.20*** 
  Inattentive Symptoms   -0.27**    -0.45*** 
  Hyperactive/Impulsive Symptoms 0.09             -0.08 
Cumulative R
2
 0.13    0.41*** 
 
Note: Betas presented are standardized betas for the full model.   
Both significant and non significant betas are presented.   
*p<.05, **p<.01, ***p<.001.    
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Table 7. Intercorrelations among PedsQL™ Family Impact Module and Disease- 
Specific Indicators of ADHD 
 
 
 
 
 
 
 
 
 
PedsQL™ Family 
Impact Module 
Vanderbil
t ADHD 
Symptom 
Score 
Vanderbi
lt 
Inattentiv
e 
Scale 
Vanderbil
t 
Hyperacti
ve-
Impulsive 
Scale 
Number 
of 
Diagnoses 
Number 
of Daily 
Medicin
es 
Numb
er of 
Mont
hs on 
Medi
cines 
Numbe
r of 
Months 
since 
Diagno
sis 
Total Impact Score -0.50*** -0.46*** -0.43*** -0.13 -0.16* -0.10 -0.07 
Parent HRQOL 
Summary 
-0.43*** -0.36*** -0.38*** -0.18* -0.18* 0.01 0.03 
Physical Functioning -0.37*** -0.30*** -0.33*** -0.18* -0.18* 0.07 0.06 
Emotional 
Functioning  
-0.46*** -0.42*** -0.38*** -0.16* -0.14 0.00 0.02 
Social Functioning -0.34*** -0.33*** -0.27*** -0.17* -0.14 -0.02 0.01 
Cognitive 
Functioning 
-0.28***   -0.18* -0.30*** -0.09 -0.15* -0.02 -0.01 
Communication -0.34*** -0.34*** -0.27*** -0.16* -0.09 0.01 0.02 
Worry -0.51*** -0.45*** -0.45*** -0.07 -0.15* 0.05 -0.05 
Family Summary -0.51*** -0.49*** -0.39*** -0.18* -0.18* -0.02 0.00 
Daily Activities -0.48*** -0.46*** -0.38*** -0.13 -0.19* -0.04 -0.01 
Family 
Relationships 
-0.44*** -0.44*** -0.34*** -0.11 -0.11 -0.12 -0.10 
 
 
Note: *p<.05, **p<.01, ***p<.001.    
Effect sizes are designated as small (0.10), medium (0.30), and large (0.50) for Pearson’s  
product moment correlations. 
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Table 8. Intercorrelations among PedsQL™ 4.0 Generic Core Scales and PedsQL™  
Family Impact Module for Child Self-Report 
 
 
 
 
Child Self-Report  
 
 
 
PedsQL™ Family 
Impact Module 
Generi
c Core 
Total 
Score 
 
Physical 
Health 
 
Psycho
social 
Health 
 
Emotion
al 
Functio
ning 
 
Social 
Functioni
ng 
 
School 
Functioning 
Total Impact Score 0.10 0.09 0.09 0.02 0.07 0.11 
Parent HRQOL 
Summary 
0.07 0.07 0.06 0.03 0.03 0.10 
Physical 
Functioning 
0.05 0.04 0.04 0.03 0.00 0.08 
Emotional 
Functioning  
0.07 0.08 0.05 0.00 0.05 0.09 
Social Functioning  0.16* 0.14 0.15 0.08 0.15 0.12 
Cognitive 
Functioning 
-0.01 0.00 -0.01 0.01 -0.06 0.06 
Communication 0.15 0.14 0.13 0.04 0.13 0.12 
Worry 0.06 0.05 0.05 0.02 0.09 -0.01 
Family Summary 0.09 0.07 0.08 -0.03 0.06 0.16* 
Daily Activities 0.10 0.09 0.09 0.02 0.08 0.11 
Family 
Relationships 
0.07 0.05 0.07 -0.05 0.04 0.17* 
  
Note: *p<.05, **p<.01, ***p<.001.    
     Effect sizes are designated as small (0.10), medium (0.30), and large (0.50) for  
     Pearson’s product Moment correlations. 
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Table 9. Intercorrelations among PedsQL™ 4.0 Generic Core Scales and PedsQL™ 
Family Impact Module for Parent Proxy-Report 
 
 
 
 
Parent Proxy-Report  
 
 
 
PedsQL™ Family Impact 
Module 
Generi
c Core 
Total 
Score 
 
Physi
cal 
Healt
h 
 
Psychosoc
ial Health 
 
Emotional 
Functioni
ng 
 
Social 
Functio
ning 
 
School 
Functionin
g 
Total Impact Score 0.50**
* 
0.30*
** 
0.55*** 0.50*** 0.47*** 0.44*** 
Parent HRQOL 
Summary 
0.44**
* 
0.27*
** 
0.47*** 0.44*** 0.41*** 0.36*** 
Physical Functioning 0.34**
* 
0.21*
* 
0.38*** 0.37*** 0.30*** 0.29*** 
Emotional Functioning  0.44**
* 
0.26*
* 
0.49*** 0.46*** 0.42*** 0.37*** 
Social Functioning 0.42**
* 
0.25*
* 
0.46*** 0.38*** 0.45*** 0.35*** 
Cognitive Functioning 0.29**
* 
0.22*
* 
0.29** 0.27***      
0.25** 
    0.23** 
Communication 0.41**
* 
0.26*
* 
0.45*** 0.42*** 0.37*** 0.38*** 
Worry 0.41**
* 
0.24*
* 
0.46*** 0.43*** 0.37*** 0.38*** 
Family Summary 0.46**
* 
0.27*
** 
0.52*** 0.47*** 0.43*** 0.45*** 
Daily Activities 0.46**
* 
0.27*
** 
0.52*** 0.48*** 0.42*** 0.45*** 
Family Relationships 0.40**
* 
0.23*
* 
0.45*** 0.40*** 0.37*** 0.39*** 
 
Note: *p<.05, **p<.01, ***p<.001.    
Effect sizes are designated as small (0.10), medium (0.30), and large (0.50) for 
Pearson’s product moment correlations. 
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Table 10. Hierarchical Linear Regression Models for Factors Associated  
with Family Impact 
 
Variables PedsQL™ Family 
Impact Total 
Score 
 
Block 1 (demographic variables)  
  R
 2 0.06 
  Gender 0.04 
  Race/Ethnicity  0.05 
  Socioeconomic Status 0.04 
  Age 0.08 
Block 2 (disease-specific 
indicators/ADHD symptom severity) 
 
  R
 2 change      0.22*** 
  Number of daily ADHD medications -0.14 
  Months on daily ADHD medications -0.05 
  Months since ADHD Diagnosis 0.06 
  Presence of Co-Morbid Diagnosis -0.03 
  Number of Diagnoses 0.06 
  Vanderbilt ADHD Symptom Score    -0.29*** 
Block 3 (child psychosocial 
functioning) 
 
  R
 2 change      0.09*** 
  PedsQL™ Emotional Functioning 
Scale 
0.13 
  PedsQL™ Social Functioning Scale    0.29** 
  PedsQL™ School Functioning Scale             -0.04 
Cumulative R
2
     0.38*** 
 
Note: PedsQL™ Emotional Functioning Scale, Social Functioning Scale, and 
School Functioning 
Scale entered in Block 3 are parent proxy-report.   
Betas presented are standardized betas for the full model.   
*p<.05, **p<.01, ***p<.001.    
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Table 11. Comparisons between PedsQL 4.0 Generic Core Scales for Child Self-Report 
and Parent Proxy-Report for ADHD Sample  
 
 
Child Self-Report a 
  
Parent Proxy-
Report b 
  
Differences 
 
Effect 
Size 
Scale Mean  SD  Mean SD     
 
 
(n = 177) 
   
Total Score 66.99 15.88  58.42 18.19  a>b*** 0.50 
Physical Health 76.45 17.65  70.90 24.61      a>b* 0.26 
Psychosocial Health 61.94 17.66  51.76 18.02  a>b*** 0.57 
Emotional Functioning 59.27 23.52  48.35 20.61  a>b*** 0.49 
Social Functioning 66.61 24.96  58.79 22.99      a>b** 0.33 
School Functioning  60.16 20.59  48.10 19.23  a>b*** 0.61 
 
Note: *p<.05, **p<.01, ***p<.001.      
SD = standard deviation.  
Effect sizes are designated as small (.20), medium (.50), and large (.80).  
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